10:18 AM EST, 11/06/2025 (MT Newswires) -- Amylyx Pharmaceuticals ( AMLX ) shares were over 4% lower in recent Thursday trading following its Q3 results.

Earlier, the company reported a Q3 net loss of $0.37 per diluted share, narrower than a loss of $1.07 a year earlier. Analysts polled by FactSet expected a loss of $0.44.

The company didn't report any revenue in the quarter.

Amylyx said it expects its cash runway to extend into 2028 based on its current operating plans.

Price: 12.69, Change: -0.55, Percent Change: -4.15